Management of Anxiety and Depression During Fentanyl Detox

Understanding Withdrawal vs. Primary Psychiatric Symptoms

Anxiety and depressive symptoms routinely emerge or intensify during opioid withdrawal and are core features of the acute withdrawal syndrome, according to the Mayo Clinic Proceedings 1
Pain itself may be a withdrawal symptom and not simply an exacerbation of original chronic pain, as descending pain facilitatory tracts show increased firing during early abstinence, as noted by the Mayo Clinic Proceedings 1

Address reversible causes first by exploring the patient's concerns and anxieties, ensuring effective communication, and explaining the withdrawal process, as recommended by the BMJ 2
Benzodiazepines are appropriate for managing anxiety during acute withdrawal: Start lorazepam 0.5-1 mg orally four times daily as needed, or reduce to 0.25-0.5 mg in elderly patients, according to the BMJ 2
For patients unable to swallow, use midazolam 2.5-5 mg subcutaneously every 2-4 hours as required, as suggested by the BMJ 2

SSRIs take up to 6 weeks to show effect, making them unsuitable for managing acute withdrawal symptoms, as stated by Circulation 3
The efficacy of SSRIs in treating depression in patients with substance use disorders is mixed, according to Circulation 3

Protracted withdrawal symptoms can persist for months after opioid elimination and must be differentiated from primary psychiatric disorders, as noted by the Mayo Clinic Proceedings 1
These symptoms cannot be easily differentiated from chronic pain-related mood symptoms in patients who have not been treated with opioids, according to the Mayo Clinic Proceedings 1

Do not mistake withdrawal symptoms for primary psychiatric illness requiring immediate antidepressant therapy, as warned by the Mayo Clinic Proceedings 1
Do not undertreat acute withdrawal symptoms with inadequate benzodiazepine dosing, as this leads to treatment dropout and early opioid resumption, as cautioned by the Mayo Clinic Proceedings 1
Fear of withdrawal and worsening pain are primary reasons patients continue opioid use and drop out of treatment—these must be addressed proactively with adequate symptom management, as emphasized by the Mayo Clinic Proceedings 1

Observe for at least 2 hours after any naloxone administration if used, as resedation can occur, as recommended by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4
Continuous monitoring of vital signs is essential during acute withdrawal management, as stated by Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4
Document withdrawal severity using standardized assessment tools, as suggested by Intensive Care Medicine 5